MX9606654A - Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina. - Google Patents
Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.Info
- Publication number
- MX9606654A MX9606654A MX9606654A MX9606654A MX9606654A MX 9606654 A MX9606654 A MX 9606654A MX 9606654 A MX9606654 A MX 9606654A MX 9606654 A MX9606654 A MX 9606654A MX 9606654 A MX9606654 A MX 9606654A
- Authority
- MX
- Mexico
- Prior art keywords
- tachykinin antagonists
- antagonists
- tachykinin
- substituted alkyldiamine
- derivatives
- Prior art date
Links
- 102000003141 Tachykinin Human genes 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title abstract 3
- 108060008037 tachykinin Proteins 0.000 title abstract 3
- 206010011224 Cough Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/262,209 US5597845A (en) | 1994-06-20 | 1994-06-20 | Substituted alkyldiamine derivatives |
| PCT/US1995/006317 WO1995035279A1 (en) | 1994-06-20 | 1995-05-19 | Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9606654A true MX9606654A (es) | 1997-12-31 |
Family
ID=22996631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9606654A MX9606654A (es) | 1994-06-20 | 1995-05-19 | Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5597845A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0767783B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3920916B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100371981B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1083429C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE169905T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU691619B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2193348C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69504198T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0767783T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2121389T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI115135B (cg-RX-API-DMAC7.html) |
| HU (1) | HUT75965A (cg-RX-API-DMAC7.html) |
| IL (1) | IL114185A (cg-RX-API-DMAC7.html) |
| MX (1) | MX9606654A (cg-RX-API-DMAC7.html) |
| NO (1) | NO307458B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ287291A (cg-RX-API-DMAC7.html) |
| TW (1) | TW442451B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1995035279A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA954947B (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW541295B (en) * | 1999-01-05 | 2003-07-11 | Nippon Zoki Pharmaceutical Co | A novel substituted alkylteraamine derivative for use as tachykinin antagonist |
| US6613801B2 (en) * | 2000-05-30 | 2003-09-02 | Transtech Pharma, Inc. | Method for the synthesis of compounds of formula I and their uses thereof |
| JP2004523565A (ja) | 2001-03-05 | 2004-08-05 | トランス テック ファーマ，インコーポレイテッド | 治療因子としてのベンゾイミダゾール誘導体 |
| CN1494425B (zh) | 2001-03-05 | 2011-12-07 | 特兰斯泰克制药公司 | 用作治疗剂的羧酰胺衍生物 |
| ATE529110T1 (de) | 2002-03-05 | 2011-11-15 | Transtech Pharma Inc | Mono- und bicyclische azolderivate die die interaktion von liganden mit rage hemmen |
| US20090263370A1 (en) * | 2006-11-30 | 2009-10-22 | Guoliang Tao | Methods for treating tachykinin-mediated diseases with cholinesterase |
| TWI517850B (zh) | 2009-09-30 | 2016-01-21 | Ｖｔｖ治療有限責任公司 | 經取代之咪唑衍生物及其使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164372A (en) * | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
| WO1994004494A1 (en) * | 1992-08-13 | 1994-03-03 | Warner-Lambert Company | Tachykinin antagonists |
| EP0593559A1 (en) * | 1991-07-05 | 1994-04-27 | MERCK SHARP & DOHME LTD. | Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
-
1994
- 1994-06-20 US US08/262,209 patent/US5597845A/en not_active Expired - Fee Related
-
1995
- 1995-05-19 HU HU9603540A patent/HUT75965A/hu not_active Application Discontinuation
- 1995-05-19 CN CN95193680A patent/CN1083429C/zh not_active Expired - Fee Related
- 1995-05-19 ES ES95920539T patent/ES2121389T3/es not_active Expired - Lifetime
- 1995-05-19 MX MX9606654A patent/MX9606654A/es not_active IP Right Cessation
- 1995-05-19 CA CA002193348A patent/CA2193348C/en not_active Expired - Fee Related
- 1995-05-19 DK DK95920539T patent/DK0767783T3/da active
- 1995-05-19 DE DE69504198T patent/DE69504198T2/de not_active Expired - Fee Related
- 1995-05-19 AU AU25961/95A patent/AU691619B2/en not_active Ceased
- 1995-05-19 EP EP95920539A patent/EP0767783B1/en not_active Expired - Lifetime
- 1995-05-19 NZ NZ287291A patent/NZ287291A/xx unknown
- 1995-05-19 WO PCT/US1995/006317 patent/WO1995035279A1/en not_active Ceased
- 1995-05-19 KR KR1019960707303A patent/KR100371981B1/ko not_active Expired - Fee Related
- 1995-05-19 JP JP50217396A patent/JP3920916B2/ja not_active Expired - Fee Related
- 1995-05-19 AT AT95920539T patent/ATE169905T1/de not_active IP Right Cessation
- 1995-06-14 ZA ZA954947A patent/ZA954947B/xx unknown
- 1995-06-15 TW TW084106131A patent/TW442451B/zh not_active IP Right Cessation
- 1995-06-16 IL IL11418595A patent/IL114185A/xx not_active IP Right Cessation
-
1996
- 1996-12-18 FI FI965097A patent/FI115135B/fi not_active IP Right Cessation
- 1996-12-19 NO NO965469A patent/NO307458B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO307458B1 (no) | 2000-04-10 |
| DK0767783T3 (da) | 1999-05-25 |
| FI115135B (fi) | 2005-03-15 |
| TW442451B (en) | 2001-06-23 |
| ATE169905T1 (de) | 1998-09-15 |
| JP3920916B2 (ja) | 2007-05-30 |
| NZ287291A (en) | 1998-10-28 |
| IL114185A (en) | 1999-07-14 |
| WO1995035279A1 (en) | 1995-12-28 |
| HU9603540D0 (en) | 1997-02-28 |
| DE69504198T2 (de) | 1999-04-29 |
| CA2193348C (en) | 1999-08-24 |
| NO965469L (no) | 1997-02-19 |
| AU2596195A (en) | 1996-01-15 |
| CA2193348A1 (en) | 1995-12-28 |
| KR100371981B1 (ko) | 2003-06-12 |
| US5597845A (en) | 1997-01-28 |
| JPH10501551A (ja) | 1998-02-10 |
| CN1083429C (zh) | 2002-04-24 |
| EP0767783A1 (en) | 1997-04-16 |
| IL114185A0 (cg-RX-API-DMAC7.html) | 1995-10-31 |
| ZA954947B (en) | 1996-01-31 |
| ES2121389T3 (es) | 1998-11-16 |
| AU691619B2 (en) | 1998-05-21 |
| EP0767783B1 (en) | 1998-08-19 |
| CN1155883A (zh) | 1997-07-30 |
| NO965469D0 (no) | 1996-12-19 |
| FI965097L (fi) | 1996-12-18 |
| HUT75965A (en) | 1997-05-28 |
| FI965097A0 (fi) | 1996-12-18 |
| DE69504198D1 (de) | 1998-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2162061T3 (es) | Derivados de piperidina como antagonistas de la neuroquinina. | |
| ES2158345T3 (es) | Derivados de piperazino como antagonistas de la neuroquinina. | |
| TW341573B (en) | New erythromycin derivatives, their preparation process and their use as medicaments | |
| DE60220422D1 (de) | Substituierte pyrazoloverbindungen zur behandlung von entzündungen | |
| TR200101969T2 (tr) | Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları. | |
| ES2164657T3 (es) | Derivados aza-biciclicos puenteados como antagonistas de la sustancia p. | |
| KR860005001A (ko) | 세제 조성물 | |
| ES2154686T3 (es) | Compuestos de piridazino-quinolina. | |
| BG104902A (en) | Semi-synthetic ecteinascidins | |
| MX9606654A (es) | Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina. | |
| PT80817A (en) | Process for the preparation of carbamates,thiocarbamates and dithiocarbamates and their substituted derivatives containing aromatic radicals | |
| ES2109276T3 (es) | Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas. | |
| DE69629023D1 (de) | Piperazino-derivative als neurokininantagonisten | |
| DE69725457D1 (de) | Piperazinderivate als neurokinin-antagonisten | |
| MX9700807A (es) | Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos. | |
| BG104232A (bg) | Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства | |
| ES2162686T3 (es) | Nuevos derivados carboxamidas ciclicos sustituidos por carboxi. | |
| MX9303966A (es) | Derivados de benzotiazepina y benzoxazepina. | |
| ES2177539T3 (es) | Benzoxacinas 4-oxo- y 4h-imidazo(5,1-c)(1,4) utilez como agentes de union de receptores de benzodiacepina. | |
| ES2078431T3 (es) | Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas. | |
| ATE117692T1 (de) | Organozinnverbindungen mit antitumoraktivität und zusammensetzungen mit antitumorwirkung. | |
| MX9706872A (es) | Derivados de piperazinona sustituidos por heterociclico como antagonistas de receptor de taquiquinina. | |
| ES8708226A1 (es) | Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina | |
| DE50100429D1 (de) | 2-,5-,6-,7-,8-Substituierte Oct-2-en-4-one | |
| FR2391205A1 (fr) | Derives de chromane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| PD | Change of proprietorship |
Owner name: AVENTIS INC. |
|
| MM | Annulment or lapse due to non-payment of fees |